NormaLyte Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 1
Employees
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

NormaLyte General Information

Description

Owner and operator of a healthcare and medical company. The company offers a clinically developed sugar-free oral rehydration salt medical product to treat patients suffering from dehydration.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Medical Supplies
Other Industries
Other Devices and Supplies
Primary Office
  • 204 South Floyd Street
  • Louisville, KY 40202
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NormaLyte Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 29-Jul-2015 Completed Startup
To view NormaLyte’s complete valuation and funding history, request access »

NormaLyte Patents

NormaLyte Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210169104-A1 Oral rehydration composition Pending 11-Aug-2014 00000000

NormaLyte Executive Team (1)

Name Title Board Seat Contact Info
Sam Lee Founder & Chief Executive Officer
To view NormaLyte’s complete executive team members history, request access »

NormaLyte Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NormaLyte Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
XLerateHealth Accelerator/Incubator 000 0000 000000 0
To view NormaLyte’s complete investors history, request access »